scholarly article | Q13442814 |
P356 | DOI | 10.1074/JBC.M100846200 |
P698 | PubMed publication ID | 11279141 |
P2093 | author name string | Li J | |
Li X | |||
Barton RW | |||
Marcu KB | |||
Massa P | |||
Peet GW | |||
Balzarano D | |||
P2860 | cites work | PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis | Q22003766 |
Rel/NF-kappaB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors | Q22010043 | ||
ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway | Q22010492 | ||
Functional isoforms of IkappaB kinase alpha (IKKalpha) lacking leucine zipper and helix-loop-helix domains reveal that IKKalpha and IKKbeta have different activation requirements | Q22253369 | ||
Structure of the human and murine R-ras genes, novel genes closely related to ras proto-oncogenes | Q24296310 | ||
PAC-1: a Mitogen-Induced Nuclear Protein Tyrosine Phosphatase | Q24308342 | ||
The NF-kappa B and I kappa B proteins: new discoveries and insights | Q24313579 | ||
IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex | Q24316469 | ||
Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation | Q24316905 | ||
BID: a novel BH3 domain-only death agonist | Q24320091 | ||
Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin | Q24320304 | ||
IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation | Q24321727 | ||
A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB | Q24321775 | ||
IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK | Q24321797 | ||
IkappaB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex | Q24530641 | ||
IKK1-deficient mice exhibit abnormal development of skin and skeleton | Q24604269 | ||
Cluster analysis and display of genome-wide expression patterns | Q24644463 | ||
Expression monitoring by hybridization to high-density oligonucleotide arrays | Q27860473 | ||
NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses | Q27861101 | ||
Attenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1 | Q28138628 | ||
Regulation of LEF-1/TCF transcription factors by Wnt and other signals | Q28141939 | ||
Identification and characterization of an IkappaB kinase | Q28245341 | ||
The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation | Q28252726 | ||
LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function [corrected] | Q28268708 | ||
MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase | Q28278415 | ||
Expression of the chemokine receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2 | Q28284326 | ||
CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs | Q28594485 | ||
A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death | Q28594815 | ||
Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination | Q28615601 | ||
Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway | Q28615706 | ||
Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients | Q28647597 | ||
Activators and target genes of Rel/NF-kappaB transcription factors | Q29547882 | ||
Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation | Q29617419 | ||
Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function | Q29617462 | ||
Immunoregulatory properties of ISG15, an interferon-induced cytokine | Q33610088 | ||
Development and maturation of secondary lymphoid tissues. | Q33652498 | ||
NF-kappaB as a primary regulator of the stress response | Q33771784 | ||
The role of chemokines in regulating cell migration during humoral immune responses | Q33778602 | ||
How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex | Q33797139 | ||
Control of apoptosis by Rel/NF-kappaB transcription factors | Q33797163 | ||
Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs | Q34756572 | ||
Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation | Q35754641 | ||
Identification of a mammary transforming gene (MAT1) associated with mouse mammary carcinogenesis | Q35812831 | ||
The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis | Q36368249 | ||
Transcriptional cross talk between NF-kappaB and p53. | Q39445554 | ||
Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli | Q40021143 | ||
Regulation of CD40 ligand expression and use of recombinant CD40 ligand for studying B cell growth and differentiation | Q40598950 | ||
Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis. | Q40907792 | ||
Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice | Q40956523 | ||
Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction | Q40962119 | ||
Severe liver degeneration in mice lacking the IkappaB kinase 2 gene | Q40962152 | ||
Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. | Q41093059 | ||
Mitogen-activated protein kinase cascades and regulation of gene expression | Q41102936 | ||
STATs and MAPKs: obligate or opportunistic partners in signaling | Q41147086 | ||
Characterization of the mouse cyclin D3 gene: exon/intron organization and promoter activity | Q41190286 | ||
Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation | Q41450875 | ||
Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase | Q41644582 | ||
Signal transduction through NF-kappa B. | Q41724478 | ||
Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc | Q42444174 | ||
Limb and skin abnormalities in mice lacking IKKalpha | Q42470314 | ||
Regulators of G-protein signaling (RGS) 1 and 16 are induced in response to bacterial lipopolysaccharide and stimulate c-fos promoter expression | Q42473246 | ||
Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. | Q52190101 | ||
Notch1 is essential for postimplantation development in mice. | Q52512097 | ||
MyD genes in negative growth control. | Q52567926 | ||
Frequent Down-Regulation and Lack of Mutation of the KAI1 Metastasis Suppressor Gene in Epithelial Ovarian Carcinoma | Q56927887 | ||
P433 | issue | 21 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | NF-κB | Q411114 |
P1104 | number of pages | 12 | |
P304 | page(s) | 18579-18590 | |
P577 | publication date | 2001-02-21 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Novel NEMO/IkappaB kinase and NF-kappa B target genes at the pre-B to immature B cell transition | |
P478 | volume | 276 |
Q28572940 | A comprehensive analysis of cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat pancreatic beta-cells |
Q36115328 | A finer tuning of G-protein signaling through regulated control of RGS proteins |
Q39647760 | Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B. |
Q24675683 | Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cells |
Q28505147 | Batf coordinates multiple aspects of B and T cell function required for normal antibody responses |
Q42667002 | Bcl-2 blocks 2-methoxyestradiol induced leukemia cell apoptosis by a p27(Kip1)-dependent G1/S cell cycle arrest in conjunction with NF-kappaB activation |
Q30952817 | Berbamine, a novel nuclear factor kappaB inhibitor, inhibits growth and induces apoptosis in human myeloma cells |
Q51778116 | Blockade of dopamine D1-like receptor signalling protects mice against OVA-induced acute asthma by inhibiting B-cell activating transcription factor signalling and Th17 function. |
Q40168608 | Bridging the gap between in silico and cell-based analysis of the nuclear factor-kappaB signaling pathway by in vitro studies of IKK2. |
Q34766937 | CXCL12 controls over-invasion of trophoblasts via upregulating CD82 expression in DSCs at maternal-fetal interface of human early pregnancy in a paracrine manner. |
Q36119506 | Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation |
Q36068315 | Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15. |
Q33784498 | Circadian disruption accelerates tumor growth and angio/stromagenesis through a Wnt signaling pathway |
Q34514908 | Circuitry of nuclear factor kappaB signaling |
Q40949171 | Computationally identifying novel NF-kappa B-regulated immune genes in the human genome |
Q36369816 | Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells |
Q42319925 | Control of translational activation by PIM kinase in activated B-cell diffuse large B-cell lymphoma confers sensitivity to inhibition by PIM447. |
Q37891671 | Cross-Regulation Between Wnt and NF-κB Signaling Pathways |
Q46870562 | Direct manipulation of activator protein-1 controls thymocyte proliferation in vitro |
Q24679432 | EBNA2 and Activated Notch Induce Expression of BATF |
Q35857559 | Effects of parathyroid hormone-related protein and macrophage inflammatory protein-1α in Jurkat T-cells on tumor formation in vivo and expression of apoptosis regulatory genes in vitro |
Q41161233 | Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1beta, and nuclear factor kappaB in trinitrobenzene sulphonic acid induced colitis in rats |
Q47864330 | Elucidating Pro-Inflammatory Cytokine Responses after Traumatic Brain Injury in a Human Stem Cell Model |
Q46314101 | Embryo mortality in Isg15-/- mice is exacerbated by environmental stress |
Q34347958 | Epstein-barr virus-induced changes in B-lymphocyte gene expression |
Q28216526 | Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein |
Q35570457 | Expression of the metastasis suppressor KAI1 in decidual cells at the human maternal-fetal interface: Regulation and functional implications |
Q37820056 | For better or for worse: the role of Pim oncogenes in tumorigenesis |
Q33526358 | Genomic profiling of messenger RNAs and microRNAs reveals potential mechanisms of TWEAK-induced skeletal muscle wasting in mice |
Q27863761 | High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction |
Q60953217 | Hypermethylated and its clinical significance in colorectal cancer |
Q38363101 | IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program. |
Q34984184 | IKKα/CHUK regulates extracellular matrix remodeling independent of its kinase activity to facilitate articular chondrocyte differentiation. |
Q33767461 | IL-17 activates the canonical NF-kappaB signaling pathway in autoimmune B cells of BXD2 mice to upregulate the expression of regulators of G-protein signaling 16. |
Q40700858 | IRF3 mediates a TLR3/TLR4-specific antiviral gene program |
Q37691938 | ISG15 and immune diseases |
Q33925311 | ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus |
Q40079195 | ISGylation - a key to lock the cell gates for preventing the spread of threats |
Q47375261 | Increased BATF expression is associated with the severity of liver damage in patients with chronic hepatitis B. |
Q28588786 | Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice |
Q40324196 | Infection of bovine cells by the protozoan parasite Theileria annulata modulates expression of the ISGylation system. |
Q92703239 | Interplay between Intrinsic and Innate Immunity during HIV Infection |
Q37437166 | Intrinsic resistance to PIM kinase inhibition in AML through p38α-mediated feedback activation of mTOR signaling |
Q40749748 | Lipopolysaccharide activates the expression of ISG15-specific protease UBP43 via interferon regulatory factor 3. |
Q35666695 | Modulation and function of caspase pathways in B lymphocytes |
Q39358853 | Modulation of activation-associated host cell gene expression by the apicomplexan parasite Theileria annulata |
Q40691037 | Molecular cloning of the fish interferon stimulated gene, 15 kDa (ISG15) orthologue: a ubiquitin-like gene induced by nephrotoxic damage |
Q41190391 | Novel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma |
Q28383134 | Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity |
Q28201984 | Nuclear transcription factor-kappaB as a target for cancer drug development |
Q35700283 | PEA-15 modulates TNFalpha intracellular signaling in astrocytes |
Q24603099 | PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers |
Q24530203 | Phosphorylation of BATF regulates DNA binding: a novel mechanism for AP-1 (activator protein-1) regulation |
Q40435824 | Polyamine depletion inhibits NF-kappaB binding to DNA and interleukin-8 production in human chondrocytes stimulated by tumor necrosis factor-alpha. |
Q40690946 | Proteasomes modulate conjugation to the ubiquitin-like protein, ISG15. |
Q24672739 | Protein ISGylation modulates the JAK-STAT signaling pathway |
Q54674737 | Proviral integration site 2 is required for interleukin-6 expression induced by interleukin-1, tumour necrosis factor-α and lipopolysaccharide. |
Q35259181 | Quantification noise in single cell experiments |
Q37183688 | R-CHOP regimen can significantly decrease the risk of disease relapse and progression in patients with non-germinal center B-cell subtype diffuse large B-cell lymphoma |
Q44223059 | Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. |
Q47637709 | Regulating the regulators: Epigenetic, transcriptional, and post-translational regulation of RGS proteins |
Q34783510 | Regulation of N-myc expression in development and disease |
Q35217391 | Retinoid target genes in acute promyelocytic leukemia |
Q38990306 | SPIB and BATF provide alternate determinants of IRF4 occupancy in diffuse large B-cell lymphoma linked to disease heterogeneity |
Q51137572 | Sumoylation and Its Contribution to Cancer. |
Q42050158 | Sustained NF-kappaB activation produces a short-term cell proliferation block in conjunction with repressing effectors of cell cycle progression controlled by E2F or FoxM1. |
Q26799499 | Targeting the Pim kinases in multiple myeloma |
Q35126481 | The IkappaB kinase complex and NF-kappaB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1. |
Q28258028 | The PIM kinases in hematological cancers |
Q39529566 | The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas |
Q30882099 | The multifunctional protein PEA-15 is involved in the control of apoptosis and cell cycle in astrocytes |
Q21143809 | The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane |
Q28508632 | The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor |
Q37295365 | The zinc finger domain of IKKγ (NEMO) protein in health and disease |
Q37760477 | Transcriptional regulation of T helper 17 cell differentiation |
Q34411407 | Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes |
Q43005466 | Tumour necrosis factor alpha and nuclear factor kappaB inhibit transcription of human TFF3 encoding a gastrointestinal healing peptide |
Q27863712 | UBP43 (USP18) specifically removes ISG15 from conjugated proteins |
Q28504645 | Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling |
Q39325888 | Up-regulation of interferon-stimulated gene15 and its conjugates by tumor necrosis factor-α via type I interferon-dependent and -independent pathways |
Q35583076 | WNT10A promotes an invasive and self-renewing phenotype in esophageal squamous cell carcinoma |
Q36826525 | c-Rel, an NF-kappaB family transcription factor, is required for hippocampal long-term synaptic plasticity and memory formation |
Q39266738 | cIAP2 represses IKKα/β-mediated activation of MDM2 to prevent p53 degradation |
Q37550036 | β2-Adrenergic receptor-dependent chemokine receptor 2 expression regulates leukocyte recruitment to the heart following acute injury |
Search more.